eLaws | eCases | United States Code | Federal Courts |
Home » 2020 Issues » 85 FR (03/30/2020) » 2020-06513. Allergenic Products Advisory Committee; Cancellation of Meeting

  2020-06513. Allergenic Products Advisory Committee; Cancellation of Meeting  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The meeting of the Allergenic Products Advisory Committee scheduled for May 15, 2020, is canceled. The Allergenic Products Advisory Committee meeting scheduled for May 15, 2020, to discuss and make recommendations on the safety and efficacy of Peanut (Arachis hypogaea) Allergen Extract manufactured by DBV Technologies, S.A, has been canceled to allow time for the FDA to review outstanding issues. The Agency intends to continue evaluating the product and will schedule an Advisory Committee meeting in the future, as needed. The meeting was announced in the Federal Register on February 24, 2020.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Kathleen Hayes, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 6307, Silver Spring, MD 20993-0002, 301-796-7864, kathleen.hayes@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting, which was announced in the Federal Register of February 24, 2020, 85 FR 10451.

    Start Signature

    Dated: March 24, 2020.

    Lowell J. Schiller,

    Principal Associate Commissioner for Policy.

    End Signature End Further Info End Preamble

    [FR Doc. 2020-06513 Filed 3-27-20; 8:45 am]

    BILLING CODE 4164-01-P

Visit the Official Version
Leave a Comment

Document Information

Published:
03/30/2020
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2020-06513
Pages:
17583-17583 (1 pages)
Docket Numbers:
Docket No. FDA-2020-N-0008
PDF File:
2020-06513.pdf
Supporting Documents:
» General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee, Notice of Meeting
» Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
» Request for Nominations for Individuals and Consumer Organizations for Advisory Committees
» Advisory Committee; Cellular, Tissue and Gene Therapies Advisory Committee; Renewal
» Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Postponement
» Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
» Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
» Patient Engagement Advisory Committee; Notice of Meeting
» Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
» Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting